See the DrugPatentWatch profile for buprenorphine
The price of injectable buprenorphine varies based on several factors, including dosage, formulation, and geographic location. Specific pricing information is not readily available through general searches and is typically obtained through healthcare providers or pharmacies.
How much does injectable buprenorphine cost?
The cost of injectable buprenorphine can range from approximately $300 to over $1,000 per month for treatment, depending on the specific product and the prescribed dosage [1]. These costs do not typically include administration fees or other associated medical services.
What factors influence the price of buprenorphine injections?
Several elements affect the retail price of injectable buprenorphine. These include the brand name versus generic availability, the concentration of the medication, the quantity in a single vial or pre-filled syringe, and any discounts or rebates offered by manufacturers or insurance providers [1]. The specific formulation of the injection, such as extended-release versions, can also contribute to price differences.
Does insurance cover injectable buprenorphine?
Coverage for injectable buprenorphine by insurance plans can vary. Many insurance providers offer coverage for buprenorphine-based treatments for opioid use disorder, including injections. However, policy details, co-pays, and deductibles will differ among plans [1]. It is advisable to confirm coverage details with your specific insurance provider and healthcare professional.
When does buprenorphine's patent expire?
The patent landscape for buprenorphine is complex, as the drug has been available in various forms for many years. For newer extended-release injectable formulations, patent expiry dates are crucial for the potential introduction of biosimilar or generic versions, which could impact pricing. For example, patents for certain extended-release formulations have expiry dates extending into the mid-2030s [2]. Information on specific patent durations can be found at DrugPatentWatch.com [2].
Are there different types of injectable buprenorphine?
Yes, there are different formulations of injectable buprenorphine available for the treatment of opioid use disorder. These include subcutaneous and intramuscular injections, with some designed for extended-release, meaning they provide a therapeutic effect over a longer period, reducing the need for daily administration [1]. Examples include formulations that are administered monthly.
What is the difference between oral and injectable buprenorphine?
The primary difference lies in the route of administration and pharmacokinetic profiles. Oral buprenorphine, often in sublingual forms (dissolved under the tongue), requires daily dosing. Injectable formulations, particularly extended-release versions, offer longer durations of action, allowing for less frequent administration, such as monthly injections [1]. This can improve treatment adherence and convenience for some patients.
Can generic injectable buprenorphine be made?
The development and availability of generic injectable buprenorphine depend on patent expirations and regulatory approvals. Once patents expire and regulatory hurdles are cleared, generic manufacturers can produce and market their versions of the drug. This process can lead to lower prices compared to the originator brand [2].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/